Envista Holdings Co. (NYSE:NVST) Shares Sold by SG Americas Securities LLC

SG Americas Securities LLC reduced its position in Envista Holdings Co. (NYSE:NVST) by 91.7% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 4,287 shares of the company’s stock after selling 47,420 shares during the period. SG Americas Securities LLC’s holdings in Envista were worth $103,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Vanguard Group Inc. boosted its holdings in shares of Envista by 0.4% in the third quarter. Vanguard Group Inc. now owns 16,223,171 shares of the company’s stock valued at $452,302,000 after acquiring an additional 62,463 shares during the period. Ariel Investments LLC grew its position in Envista by 4.3% during the 3rd quarter. Ariel Investments LLC now owns 5,335,578 shares of the company’s stock worth $148,756,000 after purchasing an additional 218,461 shares during the last quarter. Alliancebernstein L.P. increased its stake in Envista by 50.5% in the fourth quarter. Alliancebernstein L.P. now owns 4,209,467 shares of the company’s stock valued at $141,733,000 after purchasing an additional 1,412,915 shares during the period. Macquarie Group Ltd. raised its holdings in shares of Envista by 14.4% in the first quarter. Macquarie Group Ltd. now owns 4,157,392 shares of the company’s stock valued at $169,954,000 after buying an additional 524,622 shares during the last quarter. Finally, Eaton Vance Management boosted its stake in shares of Envista by 7.2% during the first quarter. Eaton Vance Management now owns 2,187,720 shares of the company’s stock worth $106,563,000 after buying an additional 147,127 shares during the period.

Analyst Ratings Changes

Several equities analysts recently issued reports on the company. Jefferies Financial Group cut Envista from a “buy” rating to a “hold” rating and dropped their price target for the company from $30.00 to $23.00 in a research report on Friday, February 9th. William Blair cut shares of Envista from an “outperform” rating to a “market perform” rating in a research note on Thursday, February 8th. TheStreet downgraded Envista from a “c” rating to a “d+” rating in a research note on Wednesday, February 7th. Leerink Partnrs restated an “underperform” rating on shares of Envista in a research note on Monday, February 26th. Finally, SVB Leerink initiated coverage on Envista in a research report on Monday, February 26th. They issued an “underperform” rating and a $19.00 price objective for the company. Three investment analysts have rated the stock with a sell rating, five have given a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $29.60.

Envista Trading Up 1.1 %

NYSE:NVST opened at $19.96 on Friday. Envista Holdings Co. has a 52-week low of $18.95 and a 52-week high of $39.28. The company has a quick ratio of 1.90, a current ratio of 2.23 and a debt-to-equity ratio of 0.33. The stock has a fifty day simple moving average of $21.17 and a 200-day simple moving average of $22.93. The company has a market capitalization of $3.43 billion, a PE ratio of -32.72, a price-to-earnings-growth ratio of 3.66 and a beta of 1.35.

Envista (NYSE:NVST) last announced its earnings results on Wednesday, February 7th. The company reported $0.29 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.33 by ($0.04). The business had revenue of $645.60 million for the quarter, compared to analyst estimates of $638.37 million. Envista had a positive return on equity of 6.31% and a negative net margin of 3.90%. The business’s revenue was down 2.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.52 EPS. On average, equities research analysts expect that Envista Holdings Co. will post 1.43 earnings per share for the current fiscal year.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.